Reilly Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Reilly Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$12K	Hold	111	–	–	﹤0.01%	691
2021 Q3	$14K	Hold	111	–	–	﹤0.01%	604
2021 Q2	$15K	Sell	111 -60	-35%	-$7.89K	﹤0.01%	620
2021 Q1	$23K	Buy	171 +60	+54%	+$8.98K	﹤0.01%	518
2020 Q4	$16K	Sell	111 -185	-63%	-$23.7K	﹤0.01%	539
2020 Q3	$33K	Sell	296 -27	-8%	-$3.03K	﹤0.01%	368
2020 Q2	$36K	Hold	323	–	–	﹤0.01%	356
2020 Q1	$25K	Sell	323 -13	-4%	-$1.15K	﹤0.01%	400
2019 Q4	$32K	Sell	336 -144,949	-100%	-$12.5M	﹤0.01%	413
2019 Q3	$11.1M	Buy	145,285 +65	+0%	+$5.4K	1.36%	33
2019 Q2	$12.7M	Sell	145,220 -38,949	-21%	-$3.32M	1.6%	16
2019 Q1	$16.7M	Sell	184,169 -1,035	-0.6%	-$88K	2.16%	5
2018 Q4	$13.3M	Buy	185,204 +29,479	+19%	+$2.38M	1.94%	7
2018 Q3	$14.9M	Buy	155,725 +3,217	+2%	+$312K	1.98%	8
2018 Q2	$14.5M	Buy	152,508 +26,641	+21%	+$2.45M	2.06%	6
2018 Q1	$11M	Buy	125,867 +2,277	+2%	+$208K	1.54%	25
2017 Q4	$10.5M	Sell	123,590 -3,637	-3%	-$305K	1.49%	33
2017 Q3	$11M	Buy	127,227 +350	+0.3%	+$28.1K	1.65%	26
2017 Q2	$9.79M	Buy	+126,877	New	+$9M	1.5%	38

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Reilly Financial Advisors's XBI Position: Q4 2021 in Review

Reilly Financial Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q4 2021 at 111 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Reilly Financial Advisors first reported a position in XBI in Q2 2017 and has held it in 19 quarters since. The position peaked at $16.7M in Q1 2019. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Reilly Financial Advisors held 111 shares of State Street SPDR S&P Biotech ETF worth $12K as of Q4 2021.
Reilly Financial Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q4 2021.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #691 holding.
Reilly Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and has held it in 19 quarters since.
Reilly Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $16.7M in Q1 2019.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.